CXCL13 may promote the occurrence, development and poor prognosis of cancer by activating other oncogenic pathways such as JAK-STAT and NF-KB pathways) through chemokine pathway or cytokine receptor pathway. The gene discussed is NFKB1; the disease is cancer.